VIT vitura health limited

Investment view – Add recommendation and A$3.03 price target...

  1. 24,987 Posts.
    lightbulb Created with Sketch. 515
    Investment view – Add recommendation and A$3.03 price target Despite recent share price weakness, we believe VIT is delivering on its strategy. Today's announcement demonstrates to us that VIT can successfully integrate strategic acquisitions and expand offshore, in line with its growth strategy. We reiterate our positive investment view on VIT due to its diversified portfolio of well-known brands, leverage to favourable industry dynamics, growth opportunities and solid earnings growth. Given FY17 includes the removal of duplicated costs following the Musashi acquisition, we are focused on multiples in this year. In our view, trading on a FY17F PE of 13.5x (or PEG of 0.5x), VIT is attractively priced for its growth profile and against the broader FMCG sector.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
6.8¢
Change
0.002(3.03%)
Mkt cap ! $45.03M
Open High Low Value Volume
6.6¢ 6.8¢ 6.6¢ $3.788K 56.02K

Buyers (Bids)

No. Vol. Price($)
4 397976 6.6¢
 

Sellers (Offers)

Price($) Vol. No.
6.8¢ 432884 3
View Market Depth
Last trade - 11.54am 15/09/2025 (20 minute delay) ?
VIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.